Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Adaptin Bio (APTN) Debt to Equity (2024 - 2026)

Adaptin Bio recorded quarterly Debt to Equity of -$0.14 in Q1 2026, up 55.49% quarter-over-quarter from -$0.3 in Q4 2024.

Adaptin Bio's Debt to Equity history runs 2 years deep, the most recent figure standing at -$0.14 for Q1 2026.

  • In Q1 2026, Debt to Equity changed N/A year-over-year to -$0.14; the TTM figure through Mar 2026 stood at -$0.14 (changed N/A YoY), while the FY2024 annual figure was -$0.3, changed N/A from the prior year.
  • Debt to Equity came in at -$0.14 for Q1 2026 at Adaptin Bio, up from -$0.3 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of -$0.14 in Q1 2026 to a low of -$0.3 in Q4 2024.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.14
Dec 31, 2024 -0.30